The formation of anti-drug antibodies in response to anti-TNF therapy was first reported by Elliott et al. 30 years ago in rheumatoid arthritis patients, with approximately half developing antibodies to the murine portion of the drug [33]. Here, TNF is linked to rheumatoid arthritis.